Scarica l'app Stockscreener
89.05
1.85%
1.62
Pre-mercato:
88.53
-0.52
-0.58%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$87.43
Aprire:
$88.35
Volume 24 ore:
5.05M
Relative Volume:
1.22
Capitalizzazione di mercato:
$43.29B
Reddito:
$6.13B
Utile/perdita netta:
$272.21M
Rapporto P/E:
161.29
EPS:
0.5521
Flusso di cassa netto:
$1.38B
1 W Prestazione:
+9.13%
1M Prestazione:
+0.77%
6M Prestazione:
+11.84%
1 anno Prestazione:
+40.61%
Intervallo 1D:
$87.64
$89.60
Intervallo di 1 settimana:
$80.81
$89.60
Portata 52W:
$61.76
$91.06
Ventas Inc Stock (VTR) Company Profile
Nome
Ventas Inc
Settore
Industria
Telefono
(312) 660-3800
Indirizzo
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, DOC, OHI, AHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
89.05 | 43.29B | 6.13B | 272.21M | 1.38B | 0.5521 |
WELL
Welltower Inc
|
227.33 | 160.48B | 11.75B | 1.46B | 2.19B | -0.6014 |
DOC
Healthpeak Properties Inc
|
21.55 | 14.86B | 2.87B | 250.10M | 1.13B | 0.3188 |
OHI
Omega Healthcare Investors Inc
|
48.06 | 14.31B | 1.24B | 655.98M | 857.80M | 2.063 |
AHR
American Healthcare Reit Inc
|
51.00 | 10.54B | 2.37B | 101.67M | 169.19M | 0.5775 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Iniziato | Goldman | Buy |
| 2025-10-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-09-19 | Iniziato | UBS | Neutral |
| 2025-06-23 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-03-07 | Aggiornamento | Argus | Hold → Buy |
| 2025-01-17 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2024-02-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | Iniziato | Deutsche Bank | Buy |
| 2024-01-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-11-07 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2023-10-11 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-10-03 | Iniziato | Wedbush | Neutral |
| 2023-09-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-06-23 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | Iniziato | Wells Fargo | Overweight |
| 2022-11-01 | Reiterato | Credit Suisse | Outperform |
| 2022-11-01 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-06-23 | Iniziato | Credit Suisse | Outperform |
| 2022-06-03 | Iniziato | CapitalOne | Overweight |
| 2022-05-18 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-02-01 | Iniziato | Credit Suisse | Neutral |
| 2022-01-20 | Aggiornamento | Mizuho | Neutral → Buy |
| 2021-12-14 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-11-22 | Downgrade | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-09-23 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2021-08-26 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | Ripresa | Mizuho | Neutral |
| 2021-06-15 | Iniziato | Wolfe Research | Outperform |
| 2021-06-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-05-13 | Aggiornamento | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | Iniziato | Robert W. Baird | Neutral |
| 2020-11-30 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2020-11-10 | Aggiornamento | Jefferies | Underperform → Hold |
| 2020-09-08 | Downgrade | Argus | Buy → Hold |
| 2020-09-02 | Ripresa | Stifel | Hold |
| 2020-08-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2020-08-14 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-03-25 | Aggiornamento | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | Downgrade | Jefferies | Buy → Underperform |
| 2020-02-28 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | Downgrade | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | Aggiornamento | Jefferies | Hold → Buy |
| 2019-12-20 | Ripresa | Mizuho | Neutral |
| 2019-12-10 | Downgrade | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | Aggiornamento | Argus | Hold → Buy |
| 2019-10-30 | Downgrade | Stifel | Buy → Hold |
| 2019-10-28 | Downgrade | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | Downgrade | Citigroup | Buy → Neutral |
Mostra tutto
Ventas Inc Borsa (VTR) Ultime notizie
Ventas clears S&P 500 healthcare benchmark, shares reflect steady REIT profile - Ad-hoc-news.de
The senior housing portfolio from Ventas Inc.stable rents and healthcare demand - Ad-hoc-news.de
Price to earnings forward of Ventas, Inc. – BOATS:VTR - TradingView
Is Ventas stock outperforming the Dow? - MSN
Ventas opens the week with a strategy focus, shares in the US healthcare REIT sector - Ad-hoc-news.de
Union Bancaire Privee UBP SA Acquires 33,030 Shares of Ventas, Inc. $VTR - MarketBeat
Sterling Capital Management LLC Cuts Holdings in Ventas, Inc. $VTR - MarketBeat
Is Ventas (VTR) Rewriting Its Risk Profile With New Outpatient Leadership And Interim Legal Steward? - simplywall.st
Ventas opens the weekend with a clear strategy focus, shares on the NYSE radar - Ad-hoc-news.de
46,134 Shares in Ventas, Inc. $VTR Purchased by OP Asset Management Ltd - MarketBeat
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Ventyx Biosciences clarifies pipeline strategy, shares react to sector volatility - Ad-hoc-news.de
Ventas Inc. highlights senior housing growth, REIT shares in S&P 500 focus - Ad-hoc-news.de
Ventas updates its senior notes filing, REIT stock under investor scrutiny - Ad-hoc-news.de
Ventas (VTR) Citi’s Miami Global Property CEO Conference 2026 Summary - Quartr
Ventas, Inc. Actuals & Estimates (NYSE:VTR) - TradingView
Ventas, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh Actuals & Estimates (BMFBOVESPA:V1TA34) - TradingView
Price to sales forward of Ventas, Inc. – NYSE:VTR - TradingView
Enterprise value to EBIT forward of Ventas, Inc. – NYSE:VTR - TradingView
Enterprise value to revenue forward of Ventas, Inc. – NYSE:VTR - TradingView
Ventas, Inc. Actuals & Estimates (BX:VEN) - TradingView
Is Holding Ventas Stock Still a Smart Move for Your Portfolio Now? - TradingView
Ventas Inc. updates leadership in outpatient medical properties, shares in S&P 500 healthcare real e - Ad-hoc-news.de
VTR Forecast — Price Target — Prediction for 2027 - TradingView
Friedenthal Financial Acquires Shares of 11,847 Ventas, Inc. $VTR - MarketBeat
SG Americas Securities LLC Has $25.48 Million Position in Ventas, Inc. $VTR - MarketBeat
Ventas Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Ventas announces leadership change in outpatient platform, shares in S&P 500 healthcare REIT focus - Ad-hoc-news.de
Ventas Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
The Senior Living Communities from Ventas Inc.healthcare real estate that runs quietly in the bac - Ad-hoc-news.de
Ventas Appoints Andrew L. Wattula as Executive Vice President of Outpatient Medical and Research - geneonline.com
Ventas, Inc. Announces Appointment of Andrew L. Wattula as Executive Vice President, Outpatient Medical & Research, Effective August 2026 - marketscreener.com
Diversified Trust Co Purchases 32,436 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas StockAnalyst consensus and dividend profile in focus - AD HOC NEWS
Ventas Inc (VTR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
World Investment Advisors Invests $1.91 Million in Ventas, Inc. $VTR - MarketBeat
Hsbc Holdings PLC Grows Stock Holdings in Ventas, Inc. $VTR - MarketBeat
Groupama Asset Managment Lowers Holdings in Ventas, Inc. $VTR - MarketBeat
Does Ventas’ Leadership Shuffle and EVP Exit to Blackstone Reframe Its Governance Narrative (VTR)? - simplywall.st
Why a senior housing campus from Ventas Inc. is drawing quiet attention - Ad-hoc-news.de
Forty three Eighteen Advisors LLC Makes New Investment in Ventas, Inc. $VTR - MarketBeat
Why Ventas’ wellness-focused senior living feels different at The Springs at Greer Gardens - Ad-hoc-news.de
Deutsche Bank Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $100 - 富途牛牛
Ventas Is Maintained at Sector Perform by Scotiabank - Moomoo
Trading the Move, Not the Narrative: (VTR) Edition - Stock Traders Daily
Ventas Named a Founding Partner of Real Estate Executive Council’s Diversity Initiative - Nareit
Scotiabank Maintains Ventas Inc(VTR.US) With Hold Rating, Cuts Target Price to $88 - 富途牛牛
Scotiabank Adjusts Price Target on Ventas to $88 From $95, Maintains Sector Perform Rating - marketscreener.com
Governors Lane LP Sells 164,931 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas Inc (VTR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Ventas Inc (VTR) Institutional Confidence - TradingKey
Ventas Inc Azioni (VTR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):